Idéal Investisseur
Français English
CAC 40 : Market open
8 174,04 pts
-0.54%


Last updated : 08/06/2026 - 11h20
🏠 Home   ➤    Stock news

DBV Technologies: Daniel Tassé to Speak on June 9 at 9:20 AM at the Goldman Sachs Global Healthcare Conference in Miami

French biotech company DBV Technologies will participate on June 9 in the 47th annual Global Healthcare Conference organized by Goldman Sachs in Miami. CEO Daniel Tassé will host an informal discussion (fireside chat).


DBV Technologies: Daniel Tassé to Speak on June 9 at 9:20 AM at the Goldman Sachs Global Healthcare Conference in Miami

CEO's Presentation in Miami

Daniel Tassé, CEO of DBV Technologies, will speak on Tuesday, June 9, 2026, at 9:20 AM EST at the 47th annual Global Healthcare Conference organized by Goldman Sachs, to be held in Miami, Florida. His presentation will take the form of an informal discussion (fireside chat) with the event attendees.

Live Broadcast and Archiving

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

A live broadcast of the fireside chat will be available online at the time of the presentation on the DBV Technologies website under the 'Investors' section (Events page). A recording will be archived on the company’s website for 90 days following the event, allowing stakeholders to review the exchanges at a later time.



Sector Santé · Biotechnologies · Vaccins et laboratoires de recherche Biotechnologie


Assurance vie

Context

Period
  • Period: 1T2026
Key reported figures
  • Revenue: 1M€dedollars
  • Net income: -47,6M€dedollars
  • Free cash flow: -49M€dedollars
Guidance from the release
  • Toute l'équipe de DBV démontre une focalisation et une rigueur exceptionnelles alors que nous abordons des étapes décisives au cours des prochains mois.
Risks mentioned
  • Augmentation significative des dépenses de R&D.
  • Perte nette en hausse à 47,6 millions de dollars.
Opportunities identified
  • Dépôt de la demande de licence biologique prévu pour 2026.

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit